These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6597349)

  • 41. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
    Poynard T; Imbert-Bismut F; Munteanu M; Ratziu V
    Expert Rev Mol Diagn; 2005 Jan; 5(1):15-21. PubMed ID: 15723588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Significance of total serum bile acids in the initial and later phases of cirrhosis].
    Brutti AM; Falchi R; Luzzi Galeazzi S; Bazzucchi M; Lorenzoni L; Grignani F
    Minerva Dietol Gastroenterol; 1983; 29(1):27-32. PubMed ID: 6843854
    [No Abstract]   [Full Text] [Related]  

  • 44. Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis.
    Kefalas CH; Murray NG; Aguanno JJ; Dockery WD; Weinstein JS; Anderson K; Klintmalm GB
    Liver Transpl; 2004 Jan; 10(1):136-40. PubMed ID: 14755791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The clinical significance of serum cholyl-glycine estimation in cirrhosis of the liver (author's transl)].
    Petera V; Prokop V; Topolcan O; Dvorák I; Karlícek V
    Cas Lek Cesk; 1982 Jun; 121(22):684-6. PubMed ID: 7105119
    [No Abstract]   [Full Text] [Related]  

  • 46. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function.
    Gerbes AL; Møller S; Gülberg V; Henriksen JH
    Hepatology; 1995 Mar; 21(3):735-9. PubMed ID: 7875671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Physiological and histological comparison of Mediterranean and alcoholic cirrhoses].
    Haeffner A
    J Med Liban; 1971; 24(1):25-35. PubMed ID: 5581152
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical and histological aspects of chronic HCV infection and cirrhosis.
    Giusti G; Pasquale G; Galante D; Russo M; Sardaro C; Gallo C; Gaeta GB
    Hepatogastroenterology; 1993 Aug; 40(4):365-9. PubMed ID: 8406307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical study on latent cirrhosis of the liver.
    Iwamura K; Inaba R
    Tokai J Exp Clin Med; 1983 Jul; 8(3):281-91. PubMed ID: 6670113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hydrothorax as a major symptom of decompensated liver cirrhosis].
    Przybylski W; Religa W
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):287-9. PubMed ID: 8234046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Value of determining erythrocyte membrane permeability in the diagnosis of chronic liver diseases].
    Kolmakov VN; Radchenko VG
    Ter Arkh; 1982; 54(2):59-62. PubMed ID: 7071775
    [No Abstract]   [Full Text] [Related]  

  • 52. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
    Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A
    Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential diagnosis between hepatic cirrhosis and chronic active hepatitis: specificity and sensitivity of physical and laboratory findings in a series from the Mediterranean area.
    Cozzolino G; Lonardo A; Francica G; Amendola F; Cacciatore L
    Am J Gastroenterol; 1983 Jul; 78(7):442-5. PubMed ID: 6869354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study.
    Siringo S; Bolondi L; Piscaglia F; Gaetani M; Misitano B; Carbone C; Corinaldesi R; Burroughs AK
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):62-8. PubMed ID: 9265582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oestrogen metabolism in cirrhosis of the liver.
    Tripathy AM; Haque SM
    J Indian Med Assoc; 1969 Nov; 53(9):440-3. PubMed ID: 5368380
    [No Abstract]   [Full Text] [Related]  

  • 58. Liver cirrhosis: an unfavorable factor for nonoperative management of blunt splenic injury.
    Fang JF; Chen RJ; Lin BC; Hsu YB; Kao JL; Chen MF
    J Trauma; 2003 Jun; 54(6):1131-6; discussion 1136. PubMed ID: 12813334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum and urinary fucose concentrations in hepatitis B-related cirrhosis and acute liver diseases.
    Sathish Kumar N; Eapen CE; Jeyamani R; Balasubramanian KA
    Clin Chim Acta; 2004 Apr; 342(1-2):233-5. PubMed ID: 15026286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.